Trust Company of the South’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Trust Company of the South's VRTX Position: Q2 2026 in Review
Trust Company of the South reduced its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2026, selling an estimated $44.3K and leaving 834 shares worth $414K. The position accounts for 0.06% of the portfolio, ranked #97.
Trust Company of the South first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $417K in Q1 2026. 1,093 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Trust Company of the South held 834 shares of Vertex Pharmaceuticals worth $414K as of Q2 2026.
- Trust Company of the South sold 100 Vertex Pharmaceuticals shares in Q2 2026, an estimated $44.3K.
- Vertex Pharmaceuticals made up 0.06% of Trust Company of the South's portfolio in Q2 2026, its #97 holding.
- Trust Company of the South first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Trust Company of the South's Vertex Pharmaceuticals position peaked at $417K in Q1 2026.
- 1,093 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Trust Company of the South's 13F filing for Q2 2026, filed 1 Jul 2026.